BK2011 Diagnostics & Research
- 4030.734
- +18.167+0.45%
Nephron Research Upgrades Illumina to Hold, Price Target at $100
HSBC Adjusts Price Target on Laboratory Corp of America Holdings to $210 From $225, Keeps Hold Rating
Twist Bioscience Analyst Ratings
Guardant Health Analyst Ratings
Guggenheim Initiates Twist Bioscience With Buy Rating, $53 Price Target
Jefferies Financial initiates coverage on Illumina with a target price of $115.
Natera Analyst Ratings
Jefferies Initiates Coverage On Natera With Buy Rating, Announces Price Target of $142
Guardant Health Analyst Ratings
Jefferies Initiates Coverage On Guardant Health With Buy Rating, Announces Price Target of $32
Illumina Analyst Ratings
Jefferies Assumes Illumina at Hold, Announces Price Target of $115
Myriad Genetics Analyst Ratings
Thermo Fisher Scientific Analyst Ratings
Mettler-Toledo Intl Analyst Ratings
Jefferies Assumes Mettler-Toledo Intl at Underperform, Raises Price Target to $1250
Jefferies Assumes Thermo Fisher Scientific at Buy, Raises Price Target to $650
Myriad Genetics Inc.: Jefferies assumes an underwriting rating of underperformance; targets $20 to $25
METTLER TOLEDO INTERNATIONAL CORPORATION: Jefferies assumes an underwriting rating of poor performance; targets a share price of $1,250 to $1,230
Agilent Technologies: Jefferies assumes that the insured amount is a position and buy rating; the target share price is $135 to $152